Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)
clinical trial
Press Enter · cited answer in seconds
0 sources
Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)
Summary
Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE) is a clinical trial[1].
Key Facts
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE) is in the country of Brazil[2].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE) is in the country of Jamaica[3].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE) is in the country of United States[4].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s instance of is recorded as clinical trial[5].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s start time is recorded as +2012-05-31T00:00:00Z[6].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s end time is recorded as +2014-01-31T00:00:00Z[7].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s main subject is recorded as anemia[8].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s number of participants is recorded as {'unit': '1', 'amount': '+38'}[9].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s title is recorded as Sparing Conversion to Abnormal TCD Elevation (SCATE) - a Phase III Clinical Trial to Compare Standard Care (Observation) With Alternative Therapy (Hydroxyurea) for Reducing the Risk of Converting to an Abnormal TCD Velocity in Children With Sickle Cell Anemia and Conditional Pre-treatment TCD Velocities.[10].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s short name is recorded as SCATE[11].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+2'}[12].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s ClinicalTrials.gov ID is recorded as NCT01531387[13].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+10'}[14].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s research intervention is recorded as hydroxycarbamide[15].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s clinical trial phase is recorded as phase III clinical trial[16].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s research site is recorded as St. Jude Children's Research Hospital[17].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s research subject recruitment status is recorded as terminated[18].
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)'s study type is recorded as interventional study[19].